CALR and myeloproliferative neoplasm: Taken together, these findings indicate negative effects of mutant CRT on MHC class I expression and T cell responses, but despite these effects, MPN CRT‐specific T cell responses are detectable in some MPN patients, particularly under the conditions of checkpoint blockade84 or following vaccination.89